|
|
 |
|
for information about our staff, directions to our boston clinic,
and details about current studies for different anxiety disorders. |
|
|
 Mark H. Pollack M.D.
Director
The Center for Anxiety and Traumatic Stress Disorders
Professor of Psychiatry
Harvard Medical School
Publications by Dr. Pollack
Dr. Pollack is Director of the Center for Anxiety and Traumatic Stress Disorders at the
Massachusetts General Hospital, and Associate Professor of Psychiatry at Harvard Medical School. He received his M.D. in 1982
from New Jersey Medical School, and completed residency and fellowship training in psychiatry at Massachusetts General Hospital.
Dr Pollack has received a Faculty Scholar Career Development Award from the National Institute of Mental Health to study the
longitudinal course of panic disorder and received funding from the National Institute of Drug Abuse to study the application
of cognitive-behavioral interventions for benzodiazepine discontinuation in panic disorder patients to the reduction of illicit
drug use in drug abusers. Currently he is principal investigator of an NIMH funded study examining the impact of recent terrorist
attacks on the development of PTSD and course of disorder in bipolar patients, and a NIDA funded study examining changes in
brain function as assessed by MR Spectroscopy and neuropsychological testing in patients on methadone maintenance. He has
published over 200 articles, reviews and chapters, and is co-editor of the books "Challenges in Clinical Practice: Pharmacologic
and Psychosocial Strategies", "Panic Disorder and Its Treatment", and "Social Phobia: Research and Practice."
Dr. Pollack serves on numerous editorial and advisory boards, as well as the Scientific Advisory Board of the Anxiety Disorders
Association of America, and the Board of Directors of the Mood and Anxiety Disorders Institute of the Massachusetts General
Hospital. His areas of clinical and research interest include the acute and long-term course and treatment of patients with
anxiety disorders, development of novel pharmacologic agents for mood and anxiety disorders, uses of combined cognitive-behavioral
and pharmacologic therapies for treatment refractory patients, presentation and treatment of anxiety in the medical setting,
and the pathophysiology and treatment of substance abuse.
|
|
 Naomi Michele Simon,
M.D., M.Sc.
Associate
Director
The Center for Anxiety and Traumatic Stress DisordersAssistant Professor in PsychiatryHarvard Medical SchoolPublications by Dr. SimonDr. Naomi M. Simon, a board-certified psychiatrist, is Associate Director
of the Center for Anxiety and Traumatic Stress Disorders at Massachusetts General Hospital. Dr. Simon received an MD from
Harvard Medical School, and completed a medical internship and residency in psychiatry at Columbia Presbyterian Hospital/
New York State Psychiatric Institute where she also served as Chief Resident. In addition, she completed fellowship training
in consultation psychiatry at Massachusetts General Hospital, and has a Masters in Epidemiology from the Harvard School of
Public Health.
Dr.
Simon’s major clinical and research interests include treatment approaches for refractory anxiety disorders, clinical
psychopharmacology of anxiety disorders, anxiety comorbid with mood disorders, complicated grief, and the presentation and
treatment of mood and anxiety disorders in the medical setting. She has served as a principal investigator
or co-investigator on numerous studies examining the phenomenology and treatment of panic disorder, generalized anxiety disorder,
social anxiety disorder, and post-traumatic stress disorder. Dr. Simon was the recipient of a 5-year Career Development Award
from the National Institute of Mental Health (NIMH K23 1831) to study treatment refractory panic disorder. She also participated
in the National Institute of Mental Health Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study.
Dr. Simon is a member of the Scientific Advisory Board of
the Anxiety Disorders Association of America, a Distinguished Fellow of the American Psychiatric Association, and an Associate
Member of the American College of Neuropsychopharmacology. She has authored or co-authored over 40 original research papers
appearing in peer-reviewed journals.
|
|
|
|
|
|
|
|
|
|
|
|
